Metrics as of 10/16/2026, 10:18 PM (Berlin time), refresh in progress.
Strata Critical Medical Stock
Strata Critical Medical, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Country
- United States
- CEO
- Melissa Tomkiel
- Employees
- 327
- Market cap
- $402 M
- IPO
- 05/11/2019
Strata Critical Medical, Inc. is dedicated to supporting healthcare providers throughout the United States by offering swift logistical management and specialized medical assistance. A significant part of their operations involves the movement of human organs for transplant, utilizing both aerial and ground…
Strata Critical Medical stock: price history
1D
+4.6%
1W
+0.2%
1M
-13.0%
6M
-0.7%
YTD
-5.6%
1Y
-10.6%
2Y
+30.5%
5Y
-55.8%
10Y
–
Next earnings date
Next earnings date
09/11/2026 (in 23 days)
Volatility around earnings
~86% stronger price swings than usual
Ask the agents about Strata Critical Medical
Analyst assessment of Strata Critical Medical
PRICE TARGET LOW
US$7.25
CONSENSUS
US$7.25
MEDIAN
US$7.25
PRICE TARGET HIGH
US$7.25
0
STRONG BUY
6
BUY
0
HOLD
0
SELL
0
STRONG SELL
6
TOTAL · Buy
As of: 17/09/2025
Strata Critical Medical stock metrics
P/E
9.09
P/B
1.4
EV/EBITDA
-41.63
RETURN ON EQUITY
-3.8%
NET MARGIN
-14.5%
DEBT/EQUITY
0.02
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
52.0%
FLOAT SHARES
46,013,737
AVG. DAILY VOLUME (30D)
837,990
Insider transactions (SEC)
Tomkiel Melissa M.
Tomkiel Melissa M.
Heyburn William A.
Heyburn William A.
Tomkiel Melissa M.
Comparable stocks
Frequently asked questions about Strata Critical Medical stock
What does Strata Critical Medical do?
Strata Critical Medical, Inc. is a company in the Healthcare sector, Medical - Care Facilities industry, headquartered in United States.
The CEO is Melissa Tomkiel, the company employs around 327 people.
The IPO was on 05/11/2019; the stock trades on NASDAQ under the ticker SRTA.
What do analysts say about Strata Critical Medical stock?
6 analysts rate the stock, the consensus is Buy (as of 17/09/2025).
The average price target is US$7.25, ranging from US$7.25 to US$7.25, with a median of US$7.25.
This is an external assessment, not a statement by Market Jury.
When does Strata Critical Medical report next?
The next earnings date is 09/11/2026.
Around past earnings, price swings were roughly 86% stronger than usual.
Does Strata Critical Medical pay a dividend?
No, Strata Critical Medical currently does not pay a dividend.
Which stocks are comparable to Strata Critical Medical?
Comparable stocks include HCA Healthcare, Tenet Healthcare, DaVita, Universal Health Services, Hims & Hers Health, LifeStance Health Group, Concentra Group Holdings Parent and Acadia Healthcare Company.
How can I get Strata Critical Medical stock analyzed?
Clicking "Analyze stock" lets five strategies assess Strata Critical Medical against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.